| PERIOD ENDING | 29-Aug-09 | 30-May-09 | 28-Feb-09 | 29-Nov-08 | | Total Revenue | 101,182 | 120,367 | 103,892 | 135,571 | | Cost of Revenue | 66,151 | 75,458 | 84,373 | 85,435 | | | Gross Profit | 35,031 | 44,909 | 19,519 | 50,136 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 32,220 | 36,144 | 43,285 | 42,783 | | Non Recurring |
-
|
-
| 4,557 |
-
| | Others | 6,286 | 6,311 | 6,610 | 5,228 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (3,475) | 2,454 | (34,933) | 2,124 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 228 | 115 | (223) | 619 | | Earnings Before Interest And Taxes | (3,247) | 2,569 | (35,156) | 2,743 | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | (3,247) | 2,569 | (35,156) | 2,743 | | Income Tax Expense | (1,116) | 884 | (6,249) | (5,971) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (2,131) | 1,685 | (28,907) | 8,714 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
| 88 | (4,755) | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (2,131) | 1,685 | (28,818) | 3,960 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($2,131) | $1,685 | ($28,818) | $3,960 |
|
0.03% Nasdaq 
Income Statement
